Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03236935
Title Phase Ib of L-NMMA and Pembrolizumab
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Jorge G. Darcourt

transitional cell carcinoma

head and neck squamous cell carcinoma

lung non-small cell carcinoma


Hodgkin's lymphoma

Advanced Solid Tumor


L-NMMA + Pembrolizumab

Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.